Skip to content

Ability to control HIV without drugs rare and transient, but linked to better outcomes, study shows

Infection with harmless hepatitis G doesn't mean that HIV treatment works better

One in three HIV infections remain undiagnosed in the UK

TMC125 is safe and effective in patients with NNRTI resistance

People with HIV and CD4 cell counts over 500 cells/mm3 have same death rate as general population, French study reveals

Study of nucleoside-sparing regimens stopped early due to high failure rates; NRTIs likely to remain therapeutic backbone for the time being

Patients switching from other PIs to unboosted atazanavir maintain viral suppression

Over 40 million now living with HIV worldwide

HIV treatment activism moves into the TB field